Press "Enter" to skip to content

Pre-clinical findings indicate UV-A light device eradicates viruses and bacteria

In a prospectus supplement dated June 4, 2021, filed with the US Securities and Exchange Commission, Aytu BioPharma, Inc. (NASDAQ: AYTU), disclosed that the Company’s…
This content is viewable by members only. Visit My Account to login or register for a 30 day free trial or Shop to make a purchase.